-
Part 3 | Session 1 Day Welcome: Debates & Controversies
-
Part 3 | Session 2 Session 3.1: Keynote & Debates
-
Part 3 | Session 3 Session 3.2: Live Cases & Discussions
-
Part 3 | Session 4 Session 3.3: Controversies
-
Part 3 | Session 5 Day Three Close
-
Part 1 | Session 1 Day Welcome: Structural Heart Disease
-
Part 1 | Session 3 Session 1.2 Live Cases & Discussions
-
Part 1 | Session 4 Session 1.3: Revalving for Transcatheter Heart Valve Failure
-
Part 1 | Session 5 Session 1.4: Live Cases & Discussions
-
Part 1 | Session 6 Day One Close
-
Part 2 | Session 1 Day Welcome: Complex PCI
-
Part 2 | Session 2 Session 2.1: Coronary Calcifications Updates
-
Part 2 | Session 3 Session 2.2: Live Cases & Discussions
-
Part 2 | Session 4 Session 2.3: Imaging Focus
-
Part 2 | Session 5 Session 2.4: Live Cases & Discussions
TIO 2024 brought together an outstanding international faculty, creating an unparalleled interactive experience that will keep the global interventional cardiology community up-to-date with the latest advancements in transcatheter treatment strategies. Featuring a combination of expert opinions, engaging discussions, insightful presentations and live cases from prominent medical centres on both sides of the Atlantic, TIO delivered the highest-quality CME-accredited education.
Related Content:
Key Learning Objectives
- Review planning and valve selection strategies in patients with prior valve failure
- Summarise recent repair and replacement data in mitral and tricuspid regurgitation
- Select suitable tools for undertaking PCI in calcified lesions
- Optimise use of imaging in daily practice
- Outline the pros and cons of using P2Y12 inhibitors universally following PCI
- Identify situations where an IVUS or OCT-guided approach are preferable
- Discuss the possible implications of TAVR becoming a care option in asymptomatic aortic stenosis
Target Audience
- Interventional Cardiologists
- Surgeons with an interest in transcatheter treatment strategies for coronary and structural heart disease
- Interventional Cardiology Nurses
More from this programme
Part 1
Day One: Structural Heart Disease
Part 2
Day Two: Complex PCI
Part 3
Day Three: Debates & Controversies
Faculty Biographies
Roxana Mehran
Professor of Medicine, Cardiology and Professor of Population Health Science and Policy
Roxana Mehran is Professor of Medicine, Cardiology and Professor of Population Health Science and Policy at the Icahn School of Medicine at Mount Sinai in New York. She is also Director of Interventional Cardiovascular Research and Clinical Trials at The Zena and Michael A Weiner Cardiovascular Institute at Mount Sinai Hospital where, over the past 5 years, she has led the development of a globally respected data and clinical coordination centre to support large, multicentre, multinational clinical trials designed to help improve outcomes and quality of life for patients undergoing interventional cardiovascular procedures. In recent years, her work has had a special emphasis on gaining a deeper understanding of anticoagulation and antiplatelet regimens post angioplasty and transcatheter valve replacement; and collection and interpretation of sex-specific data in cardiovascular clinical trials.
Roxana serves on editorial board of multiple peer reviewed journals, including …
Comments